It is 3am.
You are wide awake again.
Your mind is racing. Sleep feels impossible. Perhaps you have been feeling more anxious lately. Maybe you are more irritable than usual, struggling with brain fog or wondering why you suddenly do not feel quite like yourself.
For many women in their 40s and 50s, these changes can arrive during a stage of life when the reasons behind them are not always immediately clear.
But hormonal changes may be part of the picture.
As women move through perimenopause and menopause, changing hormone levels can affect everything from sleep and mood to energy levels and overall wellbeing.
One hormone that deserves more attention is progesterone.
Often associated primarily with pregnancy and the menstrual cycle, progesterone also plays an important role in women’s health beyond the reproductive years.
When hormones start to shift
Perimenopause is the transition leading up to menopause. It can begin several years before periods stop completely.
During this time, estrogen and progesterone levels can fluctuate significantly.
These changes may contribute to symptoms including:
- Hot flushes
- Night sweats
- Poor sleep
- Anxiety
- Mood changes
- Brain fog
- Irregular periods
- Increased emotional sensitivity
For women experiencing these changes, understanding the possible connection between hormones and symptoms can be an important first step towards finding appropriate support.
“Many women are surprised to learn that hormonal changes can affect emotional well-being just as much as physical symptoms,” says Ingrid Singels, Associate Director of Pharma Dynamics’ Scientific Division.
“These symptoms are common during the menopausal transition, but they are often overlooked or attributed to stress alone.”
That can leave women questioning themselves when their bodies may simply be moving through a significant hormonal transition.
So, what does progesterone actually do?
Progesterone is a naturally occurring hormone produced mainly by the ovaries.
It is well known for its role in regulating the menstrual cycle and supporting pregnancy. However, it also plays a role in sleep and may influence emotional wellbeing and overall hormonal balance.
During perimenopause, progesterone and estrogen levels can fluctuate.
For some women, that hormonal instability may coincide with changes in sleep, anxiety and emotional wellbeing.
Research has shown that micronised progesterone, either alone or with estrogen, may improve sleep quality and reduce night sweats and hot flushes in some perimenopausal women.
Sleep is particularly important because its disruption can affect much more than energy levels the following morning.
“Poor sleep can have a profound impact on quality of life,” explains Singels.
“When women start sleeping better, they often report improvements in mood, concentration, resilience and day-to-day functioning.”
Bioidentical progesterone vs synthetic progestins
The word “progesterone” can sometimes create confusion because not all progesterone-related medicines are the same.
There are two main categories used in women’s health: bioidentical progesterone, such as micronised progesterone, and synthetic progestins.
Micronised progesterone is chemically identical to the progesterone naturally produced by a woman’s ovaries. It has been processed into tiny particles to improve absorption by the body.
Synthetic progestins are laboratory-created compounds. They mimic some actions of progesterone but differ structurally from the natural hormone.
According to the information supplied by Pharma Dynamics, micronised progesterone has been shown to have a lower risk of side effects and health complications than synthetic progestins.
Research cited in the release has found that micronised progesterone:
- Is not linked to the same increased risk of breast cancer seen with some synthetic progestins.
- Has minimal impact on blood clot risk, also known as venous thromboembolism or VTE.
- Does not negatively affect cholesterol or blood sugar in the way some synthetic versions can.
These differences have become increasingly important as researchers have developed a better understanding of how different progesterone formulations affect the body.
Why some women remain cautious about hormone therapy
Hormone therapy can still be a difficult subject for many women.
Concerns about hormone therapy were heightened by studies published more than two decades ago. However, Singels points out that many of those studies involved older hormone formulations.
Understanding of menopause treatment has evolved considerably since then.
The distinction between different formulations is therefore an important part of the conversation.
For women considering treatment, the appropriate option should be discussed with a healthcare provider based on individual circumstances and needs.
One hormone, two pathways
There is another detail about micronised progesterone that many women may not know.
It can be prescribed in two ways: orally or vaginally.
The route used can depend on a woman’s stage of life, treatment goals and individual needs.
Oral micronised progesterone
Oral micronised progesterone is commonly prescribed as part of menopausal hormone therapy (MHT) to help protect the lining of the uterus.
When used alongside estrogen therapy, it has been shown to provide effective endometrial protection.
Oral progesterone also produces natural metabolites that can cross the blood-brain barrier. These may have a calming effect and help improve sleep quality.
Vaginal progesterone
Vaginal progesterone works differently in terms of how it is delivered.
It is widely used in reproductive medicine because it delivers the hormone directly to the lining of the uterus.
It is a well-established treatment for supporting early pregnancy, particularly during fertility treatments such as in vitro fertilisation (IVF), where it is considered standard practice.
It may also provide an alternative option for women using menopausal hormone therapy who cannot tolerate oral progesterone.
The important point is that the route and use of progesterone are not one-size-fits-all.
Medical guidance matters.
Do not dismiss persistent symptoms as “just ageing”
Perhaps one of the most important messages for women entering mid-life is not to automatically accept persistent or disruptive symptoms as something they simply have to live with.
“If you’re experiencing disrupted sleep, worsening anxiety, mood changes, night sweats or other perimenopausal symptoms that are affecting your quality of life, speak to your healthcare provider,” says Singels.
“Effective treatment options are available, and you don’t have to suffer in silence.”
Women can also support their overall wellbeing by prioritising regular exercise, a balanced diet, stress management, good sleep habits and routine health screenings.
These everyday habits form part of a broader approach to navigating hormonal changes.
A better conversation about women’s health
Perimenopause and menopause are natural stages of life.
But natural does not mean that women should ignore symptoms that are affecting their quality of life.
Understanding the role of hormones such as progesterone can help women recognise that changes in sleep, mood and wellbeing may have a hormonal component.
It can also encourage more informed conversations with healthcare providers.
For many women, the journey begins with a simple realisation:
You are not necessarily “just getting older”. Your body is changing.
And understanding those changes can make it easier to ask the right questions, explore appropriate support and move through mid-life with greater confidence.
Pharma Dynamics says it remains committed to expanding access to evidence-based women’s healthcare solutions that help women navigate hormonal transitions with greater confidence, comfort and quality of life.
